These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 28115707)

  • 1. Glucagon receptor inhibition normalizes blood glucose in severe insulin-resistant mice.
    Okamoto H; Cavino K; Na E; Krumm E; Kim SY; Cheng X; Murphy AJ; Yancopoulos GD; Gromada J
    Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2753-2758. PubMed ID: 28115707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor 21 (FGF21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice.
    Omar BA; Andersen B; Hald J; Raun K; Nishimura E; Ahrén B
    Diabetes; 2014 Jan; 63(1):101-10. PubMed ID: 24062250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute disruption of glucagon secretion or action does not improve glucose tolerance in an insulin-deficient mouse model of diabetes.
    Steenberg VR; Jensen SM; Pedersen J; Madsen AN; Windeløv JA; Holst B; Quistorff B; Poulsen SS; Holst JJ
    Diabetologia; 2016 Feb; 59(2):363-70. PubMed ID: 26537124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoglycemic Effect of Combined Ghrelin and Glucagon Receptor Blockade.
    Mani BK; Uchida A; Lee Y; Osborne-Lawrence S; Charron MJ; Unger RH; Berglund ED; Zigman JM
    Diabetes; 2017 Jul; 66(7):1847-1857. PubMed ID: 28487437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of the glucagon receptor gene before and after experimental diabetes reveals differential protection from hyperglycemia.
    Rivero-Gutierrez B; Haller A; Holland J; Yates E; Khrisna R; Habegger K; Dimarchi R; D'Alessio D; Perez-Tilve D
    Mol Metab; 2018 Nov; 17():28-38. PubMed ID: 30170980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperglycemia in rodent models of type 2 diabetes requires insulin-resistant alpha cells.
    Lee Y; Berglund ED; Yu X; Wang MY; Evans MR; Scherer PE; Holland WL; Charron MJ; Roth MG; Unger RH
    Proc Natl Acad Sci U S A; 2014 Sep; 111(36):13217-22. PubMed ID: 25157166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon blockade restores functional β-cell mass in type 1 diabetic mice and enhances function of human islets.
    Wang MY; Dean ED; Quittner-Strom E; Zhu Y; Chowdhury KH; Zhang Z; Zhao S; Li N; Ye R; Lee Y; Zhang Y; Chen S; Yu X; Leonard DC; Poffenberger G; Von Deylen A; McCorkle SK; Schlegel A; Sloop KW; Efanov AM; Gimeno RE; Scherer PE; Powers AC; Unger RH; Holland WL
    Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33619103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon Acting at the GLP-1 Receptor Contributes to β-Cell Regeneration Induced by Glucagon Receptor Antagonism in Diabetic Mice.
    Wei T; Cui X; Jiang Y; Wang K; Wang D; Li F; Lin X; Gu L; Yang K; Yang J; Hong T; Wei R
    Diabetes; 2023 May; 72(5):599-610. PubMed ID: 36826938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term inhibition of the glucagon receptor with a monoclonal antibody in mice causes sustained improvement in glycemic control, with reversible alpha-cell hyperplasia and hyperglucagonemia.
    Gu W; Yan H; Winters KA; Komorowski R; Vonderfecht S; Atangan L; Sivits G; Hill D; Yang J; Bi V; Shen Y; Hu S; Boone T; Lindberg RA; Véniant MM
    J Pharmacol Exp Ther; 2009 Dec; 331(3):871-81. PubMed ID: 19720878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia.
    Conarello SL; Jiang G; Mu J; Li Z; Woods J; Zycband E; Ronan J; Liu F; Roy RS; Zhu L; Charron MJ; Zhang BB
    Diabetologia; 2007 Jan; 50(1):142-50. PubMed ID: 17131145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal glucagon signaling and β-cell function after near-total α-cell ablation in adult mice.
    Thorel F; Damond N; Chera S; Wiederkehr A; Thorens B; Meda P; Wollheim CB; Herrera PL
    Diabetes; 2011 Nov; 60(11):2872-82. PubMed ID: 21926270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic beta-cell overexpression of the glucagon receptor gene results in enhanced beta-cell function and mass.
    Gelling RW; Vuguin PM; Du XQ; Cui L; Rømer J; Pederson RA; Leiser M; Sørensen H; Holst JJ; Fledelius C; Johansen PB; Fleischer N; McIntosh CH; Nishimura E; Charron MJ
    Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E695-707. PubMed ID: 19602585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of glucagon and insulin action reveals a role for the GLP-1 receptor in endogenous glucose production.
    Jun LS; Millican RL; Hawkins ED; Konkol DL; Showalter AD; Christe ME; Michael MD; Sloop KW
    Diabetes; 2015 Mar; 64(3):819-27. PubMed ID: 25288673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic alpha cell glucagon-liver FGF21 axis regulates beta cell regeneration in a mouse model of type 2 diabetes.
    Cui X; Feng J; Wei T; Zhang L; Lang S; Yang K; Yang J; Liu J; Sterr M; Lickert H; Wei R; Hong T
    Diabetologia; 2023 Mar; 66(3):535-550. PubMed ID: 36331598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon Receptor Blockade With a Human Antibody Normalizes Blood Glucose in Diabetic Mice and Monkeys.
    Okamoto H; Kim J; Aglione J; Lee J; Cavino K; Na E; Rafique A; Kim JH; Harp J; Valenzuela DM; Yancopoulos GD; Murphy AJ; Gromada J
    Endocrinology; 2015 Aug; 156(8):2781-94. PubMed ID: 26020795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon receptor antagonism promotes the production of gut proglucagon-derived peptides in diabetic mice.
    Lang S; Wei R; Wei T; Gu L; Feng J; Yan H; Yang J; Hong T
    Peptides; 2020 Sep; 131():170349. PubMed ID: 32561493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon receptor knockout mice are protected against acute olanzapine-induced hyperglycemia.
    Castellani LN; Peppler WT; Sutton CD; Whitfield J; Charron MJ; Wright DC
    Psychoneuroendocrinology; 2017 Aug; 82():38-45. PubMed ID: 28500893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid nanoparticle delivery of glucagon receptor siRNA improves glucose homeostasis in mouse models of diabetes.
    Neumann UH; Ho JSS; Chen S; Tam YYC; Cullis PR; Kieffer TJ
    Mol Metab; 2017 Oct; 6(10):1161-1172. PubMed ID: 29031717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of glucagon and glucagon-like peptide 1 receptors in mouse pancreatic alpha and beta cells in two models of alpha cell hyperplasia.
    Kedees MH; Grigoryan M; Guz Y; Teitelman G
    Mol Cell Endocrinol; 2009 Nov; 311(1-2):69-76. PubMed ID: 19647035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of glucagon signaling prevents or reverses diabetes onset only if residual β-cells persist.
    Damond N; Thorel F; Moyers JS; Charron MJ; Vuguin PM; Powers AC; Herrera PL
    Elife; 2016 Apr; 5():. PubMed ID: 27092792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.